NCT00116090View on ClinicalTrials.gov

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

CompletedOBSERVATIONAL
Enrollment

6,300

Participants

Timeline

Start Date

June 16, 2005

Study Completion Date

April 21, 2008

Conditions
UveitisCancerInfectionMortalityImmunosuppression
Trial Locations (4)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

21205

Johns Hopkins University, Baltimore

02114-3096

Massachusetts Eye and Ear Infirmary, Boston

97201-3098

Oregon Health Sciences University, Portland

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00116090 - Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study | Biotech Hunter | Biotech Hunter